| Product Name | MF | CAS | Details |
|---|
| 2-Amino-N-(1-phenylpropyl)acetamide hydrochloride | C11H17ClN2O | 2229441-26-1 | Details |
| N,N'-Bis(2-nitrophenyl)propanediamide | C15H12N4O6 | 96331-35-0 | Details |
| H-Asp-Pro-Gln-Phe-Tyr-OH hydrochloride salt | C32H40N6O10 | 793658-58-9 | Details |
| (1S) -1- [(2S, 3R) - N-Butyl-3- hydroxy- 1- azetidinyl] -1, 2- ethanediol | Details |
| H-DYEYLINVIHAFQYV-OH | Details |
| Boc-His(Trt)-OH | C30H31N3O4 | 32926-43-5 | Details |
| 4-Bromo-5-propylthiophene-2-carbaldehyde | C8H9BrOS | 938006-81-6 | Details |
| (4-(5-chloro-2-methylphenyl)piperazinyl)(cyclohexylamino)methane-1-thione | C18H26ClN3S | 499197-62-5 | Details |
| Ethyl 2-(4-carbamoylphenoxy)-2,2-difluoroacetate | C11H11F2NO4 | 1503160-11-9 | Details |
| 2-Phenylmethanesulfonylethan-1-amine | C9H13NO2S | 46207-70-9 | Details |
| 4-[(3,4-Dichlorophenyl)methyl]-4-fluoropiperidine hydrochloride | C12H15Cl3FN | 1864061-22-2 | Details |
| 4-(2-Fluorophenyl)-1,2-oxazol-3-amine | C9H7FN2O | 1267666-36-3 | Details |
| N-(Phosphonomethyl)-glycine potassium,50% aqueous solution | C3H7KNO5P | 70901-12-1 | Details |
| Estr-4-en-17-one | C18H26O | 3646-28-4 | Details |
| Manganese dihydrogen phosphate | H4MnO8P2 | 18718-07-5 | Details |
| 6-Chloro-4-(chloromethyl)-7-hydroxy-2H-chromen-2-one | C10H6Cl2O3 | 223420-30-2 | Details |
| 3-(4-Hydroxy-3,5-dimethoxyphenyl)-1,2-propanediol | C11H16O5 | 22805-15-8 | Details |
| Fluticasone propionate | C25H31F3O5S | 80474-14-2 | Details |
| 3-Amino-N-(2-hydroxyethyl)benzamide | C9H12N2O2 | 103956-05-4 | Details |
| 2-(Propan-2-yloxy)pyridine-3-carboxylic acid | C9H11NO3 | 1016690-39-3 | Details |
| 4-Benzyl-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester | C18H25NO4 | 167263-11-8 | Details |
| 4-[(4-Hydroxypiperidin-1-yl)sulfonyl]benzoic acid | C12H15NO5S | 1016503-99-3 | Details |
| GTF2H4 antibody | Details |
| MED6 antibody | Details |
| TRIM29 antibody | Details |
| 2-Fluoro-5-[(2-methyl-2,3-dihydro-1H-indol-1-yl)sulfonyl]benzoic acid | C16H14FNO4S | 1030149-58-6 | Details |
| Trans-2-ethoxycyclopropanecarboxylic acid | C6H10O3 | 60212-41-1 | Details |
| 2-Cyclopropyl-5,7-dimethylquinoline-4-carboxylic acid | C15H15NO2 | 897558-28-0 | Details |
| (trans)-2-Cyclopropylvinylboronic acid pinacol ester | C11H19BO2 | 849061-99-0 | Details |
| C14ORF140 Blocking Peptide | Details |
| H-VGFYESDVMGR-OH | Details |
| (1-Benzofuran-5-yl)methanamine hydrochloride | C9H10ClNO | 1881330-95-5 | Details |
| 3-Fluoro-6-methyloxane-2,4,5-triol | C6H11FO4 | 74554-11-3 | Details |
| PAHT antibody | Details |
| 1-(But-3-yn-1-yl)-4-methylazepan-4-ol | 1695399-14-4 | Details |
| 4-(Trifluoromethyl)benzyl bromide | C8H6BrF3 | 402-49-3 | Details |
| (4-Amino-3-methylpyridin-2-yl)methanol | C7H10N2O | 1314911-22-2 | Details |
| 18-Hydroxycorticosterone | C21H30O5 | 561-65-9 | Details |
| 4-[5-(Piperidin-4-yl)-1,3,4-oxadiazol-2-yl]pyridine dihydrochloride | C12H15ClN4O | 1955558-14-1 | Details |
| 2-[4-(3,4-Difluorophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid | C12H10F2N2O4 | 1052551-57-1 | Details |
| 2-(Dibenzylamino)acetamide | C16H18N2O | 861056-03-3 | Details |
| Eletriptan HBr - Bio-X ? | C22H27BrN2O2S | 177834-92-3 | Details |
| 2-(Morpholine-4-carbonyl)-3,4-dihydro-2H-1,4-benzoxazine | C13H16N2O3 | 874622-81-8 | Details |
| 4-Chloro-N-(4-methylbenzenesulfonyl)benzamide | C14H12ClNO3S | 14068-01-0 | Details |
| SARS-CoV-2 Nucleocapsid (150-169) Heavy | Details |
| N-Cyclohexyl-2-hydroxyacetamide | C8H15NO2 | 90204-88-9 | Details |
| 5-(2-Bromoethyl)-4-methyl-1,3-thiazole | C6H8BrNS | 671-24-9 | Details |
| 1,3-Dibromo-5-(bromomethyl)-2-chlorobenzene | C7H4Br3Cl | 1350760-65-4 | Details |
| (3-Fluorophenyl)methanesulfonamide | C7H8FNO2S | 919353-99-4 | Details |
| (2-Bromophenyl)(imino)methyl-lambda6-sulfanone | C7H8BrNOS | 833459-47-5 | Details |
| 1-Phenylethane-1,2-diamine | C8H12N2 | 5700-56-1 | Details |
| 1-Methyl-3,4-dihydroisoquinoline hydrochloride | C10H12ClN | 26210-39-9 | Details |
| Soyasaponin Aa | C64H100O31 | 117230-33-8 | Details |
| 1H-Imidazol-5-amine dihydrochloride | C3H7Cl2N3 | 111005-19-7 | Details |
| H-Pro-Leu-OH | C11H20N2O3 | 52899-07-7 | Details |
| CP-868388 | C26H33NO5 | 702681-67-2 | Details |
| 3-Fluoro-4-methyl-5-nitrobenzoic acid | C8H6FNO4 | 400-88-4 | Details |
| SIVmac239 - 56 | C65H105N21O25 | Details |
| MAP7 antibody | Details |
| 2,6-Dichloro-4-phenylpyridine | C11H7Cl2N | 25297-51-2 | Details |
| Pelargonidin-3-O-sophoroside | Details |
| UMOD Blocking Peptide | Details |
| Mouse Ig fraction | Details |
| 2,8-dichloro-1,5-naphthyridine | C8H4Cl2N2 | 28252-76-8 | Details |
| Myosin Light Chain Kinase (480-501) | C120H209N41O28S2 | 313642-00-1 | Details |
| 2-(3-Bromophenyl)-3-oxobutanenitrile | C10H8BrNO | 30118-02-6 | Details |
| Carmoxirole hydrochloride | C24H26N2O2.ClH | 115092-85-8 | Details |
| 7-Butyl-3-methyl-8-(3,4,5-trimethyl-1H-pyrazol-1-yl)-1H-purine-2,6(3H,7H)-dione | C16H22N6O2 | 1014010-73-1 | Details |
| ARL1 antibody | Details |
| Lpa12 antibody | Details |
| CD41 antibody (biotin) | Details |
| 4-(2,5-Dioxopyrrolidin-1-yl)butanoic acid | C8H11NO4 | 31601-68-0 | Details |
| TTC11 antibody | Details |
| 3-Fluorobenzyl isocyanate | C8H6FNO | 102422-56-0 | Details |
| 4,4,4-Trifluoro-2,3-dihydroxy-3-phenylbutanoic acid | C10H9F3O4 | 1989671-67-1 | Details |
| 3-(3-Iodophenyl)-1-methyl-1H-1,2,4-triazole | C9H8IN3 | 1566309-87-2 | Details |
| 2-(4-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperazin-1-yl)-2-methylpropanoic acid | C23H26N2O4 | 2138005-68-0 | Details |
| 2-{3-[({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)methyl]phenyl}-1,3-thiazole-4-carboxylic acid | C26H20N2O4S | 2137567-23-6 | Details |
| 3,3'-Dithiodipropionic acid di(N-hydroxysuccinimide ester) | C14H16N2O8S2 | 57757-57-0 | Details |
| 3,3,3-Trifluoro-2-methylpropanoic acid | C4H5F3O2 | 381-97-5 | Details |
| Zileuton sodium | C11H13N2NaO2S | 118569-21-4 | Details |
| 3-Chloro-6-fluoro-2-hydroxybenzaldehyde | C7H4ClFO2 | 1185112-08-6 | Details |
| 3-(3-Hydroxypropyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione | C11H12N2O3 | 35256-70-3 | Details |
| 1,4-Dichloro-5-methylphthalazine | C9H6Cl2N2 | 678193-44-7 | Details |
| 6-(Methoxycarbonyl)-4-methyl-1H-indole-2-carboxylic acid | C12H11NO4 | 2241130-61-8 | Details |
| Ac-EPRPEPRPDPRPGPELPLPC-NH2 | Details |
| 3-?Thietanemethanol 1,?1-?dioxide | C4H8O3S | 1784143-03-8 | Details |
| VSIG4 antibody | Details |
| 3,5-Dibromo-4-hydroxybenzaldehyde | C7H4Br2O2 | 2973-77-5 | Details |
| 1-(1-Methylpyrrolidine-2-carbonyl)piperazine | C10H19N3O | 1248383-26-7 | Details |
| 6-Methoxy-2,3,4,5-tetrahydro-1H-1-benzazepine | C11H15NO | 604004-23-1 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| 1-Oxaspiro[2.5]octane | C7H12O | 185-70-6 | Details |
| 4-Methoxyphenyl 4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside | C19H28O12 | 150412-80-9 | Details |
| 2-Bromo-4-methyl-6-nitroaniline | C7H7BrN2O2 | 827-24-7 | Details |
| 4,13-Diaza-18-crown 6-ether | C12H26N2O4 | 23978-55-4 | Details |
| 5-Hydroxyoxolan-2-one | C4H6O3 | 50768-69-9 | Details |
| 6-Bromoimidazo[1,5-a]pyridin-3-ol | C7H5BrN2O | 1781068-25-4 | Details |
| 14:0-12:0 NBD pg | C35H58N4NaO11P | 384833-03-8 | Details |
| (2,2-Dimethylthiolan-3-yl)methanamine hydrochloride | C7H16ClNS | 2173996-20-6 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||